Search research articles
Contact Us
Filters
Showing results (131-140 of 155) with videos related to
Page
of 16
Sort By:
Oncogene
|
July 27, 2007
Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment
M Fanelli, S Caprodossi, L Ricci-Vitiani, et al.
Cell Death and Differentiation
|
July 19, 2014
Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer
A Zeuner, F Francescangeli, P Contavalli, et al.
Minerva Cardioangiologica
|
September 24, 2005
Relationship between B-type natriuretic peptide levels and ventilatory response during cardiopulmonary exercise test in patients with chronic heart failure
A B Scardovi, C Coletta, N Aspromonte, et al.
Scientific Reports
|
February 10, 2016
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome
G Marziali, M Signore, M Buccarelli, et al.
Leukemia
|
December 12, 2012
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells
B Accordi, L Galla, G Milani, et al.
Cell Death and Differentiation
|
June 11, 2005
Endogenous activation of metabotropic glutamate receptors supports the proliferation and survival of neural progenitor cells
V Di Giorgi-Gerevini, D Melchiorri, G Battaglia, et al.
Cell Death and Differentiation
|
November 24, 2012
Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas
C Ciceroni, M Bonelli, E Mastrantoni, et al.
Cell Death and Differentiation
|
April 28, 2012
A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells
C M Tate, R Pallini, L Ricci-Vitiani, et al.
Neuropharmacology
|
July 16, 2008
Type-3 metabotropic glutamate receptors negatively modulate bone morphogenetic protein receptor signaling and support the tumourigenic potential of glioma-initiating cells
C Ciceroni, A Arcella, P Mosillo, et al.
Oncogene
|
May 23, 2012
BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition
V Coppola, M Musumeci, M Patrizii, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 155) with videos related to
Sort By:
Page
of 16
Oncogene
|
July 27, 2007
Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment
M Fanelli, S Caprodossi, L Ricci-Vitiani, et al.
Cell Death and Differentiation
|
July 19, 2014
Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer
A Zeuner, F Francescangeli, P Contavalli, et al.
Minerva Cardioangiologica
|
September 24, 2005
Relationship between B-type natriuretic peptide levels and ventilatory response during cardiopulmonary exercise test in patients with chronic heart failure
A B Scardovi, C Coletta, N Aspromonte, et al.
Scientific Reports
|
February 10, 2016
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome
G Marziali, M Signore, M Buccarelli, et al.
Leukemia
|
December 12, 2012
AMPK inhibition enhances apoptosis in MLL-rearranged pediatric B-acute lymphoblastic leukemia cells
B Accordi, L Galla, G Milani, et al.
Cell Death and Differentiation
|
June 11, 2005
Endogenous activation of metabotropic glutamate receptors supports the proliferation and survival of neural progenitor cells
V Di Giorgi-Gerevini, D Melchiorri, G Battaglia, et al.
Cell Death and Differentiation
|
November 24, 2012
Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas
C Ciceroni, M Bonelli, E Mastrantoni, et al.
Cell Death and Differentiation
|
April 28, 2012
A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells
C M Tate, R Pallini, L Ricci-Vitiani, et al.
Neuropharmacology
|
July 16, 2008
Type-3 metabotropic glutamate receptors negatively modulate bone morphogenetic protein receptor signaling and support the tumourigenic potential of glioma-initiating cells
C Ciceroni, A Arcella, P Mosillo, et al.
Oncogene
|
May 23, 2012
BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition
V Coppola, M Musumeci, M Patrizii, et al.
Page
of 16